$EHSI · Elite Health Systems Inc.
Elite Health Systems Inc. filed its 10-Q for the quarter ended September 30, 2026. Revenue was $1,276,000 (up from $0 a year earlier) driven by the PSS acquisition and Medicare Advantage member onboarding, but the net loss widened to $1,486,000 from $1,161,000. Cash and cash equivalents fell to $740,000 from $3,758,000 at year-end 2025, and the filing discloses a going-concern risk with an accumulated deficit of $16,561,000.
- Q3 revenue of $1,276,000 versus $0 in the prior-year quarter.
- Nine-month net loss of $4,312,000 versus $2,026,000 a year earlier.
- Cash fell to $740,000 from $3,758,000 at December 31, 2025.
- Accumulated deficit reached $16,561,000 at September 30, 2026.
- PSS contributed $1,097,000 of Q3 revenue, all from related parties.
Price data unavailable.
A micro-cap Medicare Advantage entrant is burning cash rapidly with going-concern risk and related-party revenue concentration.
A newly licensed Medicare Advantage plan burning cash while onboarding members, with revenue heavily dependent on related-party PSS customers.
Going-concern doubt: $740,000 cash against a $4,312,000 nine-month net loss and reliance on equity sales to fund operations. PSS revenue of $1,097,000 in Q3 comes entirely from related parties tied to CEO Dr. Jeereddi.